Advertisement

Topics

Cheplapharm gets rights to sell Orexigen's Mysimba in Germany, France, and Austria

15:40 EDT 9 Aug 2017 | Elsevier Business Intelligence

Orexigen Therapeutics Inc. granted Cheplapharm Arzneimittel GMBH rights to commercialize and distribute the obesity drug Mysi...

Original Article: Cheplapharm gets rights to sell Orexigen's Mysimba in Germany, France, and Austria

NEXT ARTICLE

More From BioPortfolio on "Cheplapharm gets rights to sell Orexigen's Mysimba in Germany, France, and Austria"

Quick Search
Advertisement
 

Relevant Topics

Obesity
Obesity is the condition in which excess fat has accumulated in the body (mostly in subcutaneous tissues). clinical obesity is considered to be present when a person has a BMI of over 30 (Oxford Dictionary of Medicine). It is becoming increasing common i...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...